- Home
- MNDO vs DYAI Comparison
MNDO vs DYAI Comparison
Compare MNDO & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDO
- DYAI
- Stock Information
- Founded
- MNDO 1995
- DYAI 1979
- Country
- MNDO Israel
- DYAI United States
- Employees
- MNDO N/A
- DYAI N/A
- Industry
- MNDO EDP Services
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MNDO Technology
- DYAI Health Care
- Exchange
- MNDO Nasdaq
- DYAI Nasdaq
- Market Cap
- MNDO 34.2M
- DYAI 28.3M
- IPO Year
- MNDO 2000
- DYAI 2004
- Fundamental
- Price
- MNDO $1.43
- DYAI $1.01
- Analyst Decision
- MNDO
- DYAI Strong Buy
- Analyst Count
- MNDO 0
- DYAI 1
- Target Price
- MNDO N/A
- DYAI $6.00
- AVG Volume (30 Days)
- MNDO 37.7K
- DYAI 58.3K
- Earning Date
- MNDO 08-05-2025
- DYAI 08-12-2025
- Dividend Yield
- MNDO 15.22%
- DYAI N/A
- EPS Growth
- MNDO N/A
- DYAI N/A
- EPS
- MNDO 0.17
- DYAI N/A
- Revenue
- MNDO $20,677,000.00
- DYAI $3,554,344.00
- Revenue This Year
- MNDO N/A
- DYAI $22.56
- Revenue Next Year
- MNDO N/A
- DYAI $30.95
- P/E Ratio
- MNDO $8.50
- DYAI N/A
- Revenue Growth
- MNDO N/A
- DYAI 57.59
- 52 Week Low
- MNDO $1.31
- DYAI $0.91
- 52 Week High
- MNDO $2.13
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- MNDO 57.83
- DYAI 55.41
- Support Level
- MNDO $1.40
- DYAI $0.91
- Resistance Level
- MNDO $1.52
- DYAI $1.03
- Average True Range (ATR)
- MNDO 0.06
- DYAI 0.05
- MACD
- MNDO 0.01
- DYAI 0.01
- Stochastic Oscillator
- MNDO 76.47
- DYAI 83.00
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.